ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
Multiple Sclerosis Journal · 2023-07 · 29 (8) · 904-925
DOI: 10.1177/13524585231168043 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Multiple Sclerosis Journal, online erschienen am 09.06.2023. Verfasst von Susana Otero-Romero und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Preventive Medicine and Epidemiology, Vall d'Hebron Barcelona Hospital, Barcelona, Spain Multiple Sclerosis Centre of Catalonia (Cemcat…. Hauptthemen laut MEDLINE: Multiple Sclerosis. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: ECTRIMS executive committee.
Abstract (Originalsprache)
Background
With the new highly active drugs available for people with multiple sclerosis (pwMS), vaccination becomes an essential part of the risk management strategy Objective: To develop a European evidence-based consensus for the vaccination strategy of pwMS who are candidates for disease-modifying therapies (DMTs).
Methods
This work was conducted by a multidisciplinary working group using formal consensus methodology. Clinical questions (defined as population, interventions, and outcomes) considered all authorized DMTs and vaccines. A systematic literature search was conducted and quality of evidence was defined according to the Oxford Centre for Evidence-Based Medicine Levels of Evidence. The recommendations were formulated based on the quality of evidence and the risk–benefit balance.
Results
Seven questions, encompassing vaccine safety, vaccine effectiveness, global vaccination strategy and vaccination in sub-populations (pediatric, pregnant women, elderly and international travelers) were considered. A narrative description of the evidence considering published studies, guidelines, and position statements is presented. A total of 53 recommendations were agreed by the working group after three rounds of consensus.
Conclusion
This first European consensus on vaccination in pwMS proposes the best vaccination strategy according to current evidence and expert knowledge, with the goal of homogenizing the immunization practices in pwMS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Preventive Medicine and Epidemiology, Vall d'Hebron Barcelona Hospital, Barcelona, Spain Multiple Sclerosis Centre of Catalonia (Cemcat), Vall d'Hebron Barcelona Hospital, Barcelona, Spain.
- CRC-SEP Nice, CHU de Nice, Universite Nice Cote d'Azur UR2CA-URRIS, Nice, France.
- Fundación Santa Fe de Bogotá, Bogotá, Colombia School of Medicine, Universidad de los Andes, Bogotá, Colombia Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Lo…
- Department NEUROFARBA, University of Florence, Florence, Italy IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.
- Department of Preventive Medicine and Epidemiology, Vall d'Hebron Barcelona Hospital, Barcelona, Spain.
- Centro para la Investigación de Enfermedades Neuroinmunológicas (CIEN), FLENI, Buenos Aires, Argentina.
ORCID-Profile: Christine Lebrun-Frénay, Maria Pia Amato, Massimo Filippi, Bernhard Hemmer, Melinda Magyari, Celia Oreja-Guevara, Aksel Siva, Sandra Vukusic, Mar Tintoré
Förderung
- ECTRIMS executive committee
Zitieren
APA
Otero-Romero, S., Lebrun-Frénay, C., Reyes, S., Amato, M. P., Campins, M., Farez, M., Filippi, M., Hacohen, Y., Hemmer, B., Juuti, R., Magyari, M., Oreja-Guevara, C., Siva, A., Vukusic, S., & Tintoré, M. (2023). ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs. Multiple Sclerosis Journal, 29(8), 904-925. https://doi.org/10.1177/13524585231168043
Vancouver
Otero-Romero S, Lebrun-Frénay C, Reyes S, Amato MP, Campins M, Farez M, et al. ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs. Multiple Sclerosis Journal. 2023;29(8):904-925. doi:10.1177/13524585231168043
BibTeX
@article{OteroRomero2023,
author = {Otero-Romero, Susana and Lebrun-Frénay, Christine and Reyes, Saúl and Amato, Maria Pia and Campins, Magda and Farez, Mauricio and Filippi, Massimo and Hacohen, Yael and Hemmer, Bernhard and Juuti, Rosa and Magyari, Melinda and Oreja-Guevara, Celia and Siva, Aksel and Vukusic, Sandra and Tintoré, Mar},
title = {ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs},
journal = {Multiple Sclerosis Journal},
year = {2023},
volume = {29},
number = {8},
pages = {904--925},
doi = {10.1177/13524585231168043}
}
EUVIMED